Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database

por Emery, Corinne, Torreton, Elodie, Dejager, Sylvie, Levy-Bachelot, Laurie, Bineau, Sébastien, Detournay, Bruno
Publicado 2020

Cost analysis of adverse events associated with non-small cell lung cancer management in France

por Chouaid, Christos, Loirat, Delphine, Clay, Emilie, Millier, Aurélie, Godard, Chloé, Fannan, Amira, Lévy-Bachelot, Laurie, Angevin, Eric
Publicado 2017

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis

por Charbonnel, Bernard, Simon, Dominique, Dallongeville, Jean, Bureau, Isabelle, Dejager, Sylvie, Levy-Bachelot, Laurie, Gourmelen, Julie, Detournay, Bruno
Publicado 2017

Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France

por Maunoury, Franck, Clément, Aurore, Nwankwo, Chizoba, Levy-Bachelot, Laurie, Abergel, Armand, Di Martino, Vincent, Thervet, Eric, Durand-Zaleski, Isabelle
Publicado 2018

Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (...

por Cottin, Vincent, Bensimon, Lionel, Raguideau, Fanny, Chaize, Gwendoline, Hakmé, Antoinette, Levy-Bachelot, Laurie, Vainchtock, Alexandre, Dallongeville, Jean, Bouvaist, Hélène, Brenot, Philippe
Publicado 2021